Data Insights
Artificial Intelligence (10)
Big Data (4)
Biosimilars (5)
Blockchain (1)
Cell & Gene Therapy (13)
Chemotherapy (1)
Cloud (1)
Corporate Governance (3)
Covid-19 (5)
Cybersecurity (4)
Digitalization (2)
Easy & Affordable (1)
Electronic Medical Record (EMR) Systems (1)
Environmental Sustainability (6)
Future of Work (2)
Genomics (10)
Health & Wellness (1)
Immuno-oncology (19)
Immunotherapy (1)
Internet of Things (2)
Microbiome (1)
Mobile Health (1)
Nanomedicine (2)
Oncology (4)
Orphan Designated Drugs (4)
Other Innovation Areas (87)
Precision and Personalized Medicine (1)
Remote Patient Monitoring (1)
Renewable Energy (1)
Robotics (2)
Small molecules (1)
Smart Hospitals (2)
Social Responsibility (3)
Virtual Care (3)
Showing 4 results out of 4
Q4 2023 update: immuno-oncology related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that immuno-oncology accounted for 14 pharmaceutical deals announced in Q4 2023,...
Q3 2023 update: immuno-oncology related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that immuno-oncology accounted for 3 pharmaceutical deals announced in...
Immuno-Oncology related patent filings increased in the pharmaceutical industry in Q2 2023
The global pharmaceutical industry experienced a 7% rise in the number of immuno-oncology-related patent applications in Q2 2023 compared with...
Innovation in oncology: Leading companies in gene therapy for cancers
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...